EMD-18807
SD1-2 fab in complex with SARS-COV-2 BA.12.1 Spike Glycoprotein.
EMD-18807
Single-particle2.2 Å
Deposition: 01/11/2023Map released: 13/03/2024
Last modified: 06/11/2024
Sample Organism:
Homo sapiens,
Severe acute respiratory syndrome coronavirus 2,
Enterobacteria phage T4
Sample: SD1-2 fab in complex with SARS-COV-2 BA.2.12.1 Spike Glycoprotein
Fitted models: 8r1c
Deposition Authors: Duyvesteyn HME
,
Ren J ,
Stuart DI
Sample: SD1-2 fab in complex with SARS-COV-2 BA.2.12.1 Spike Glycoprotein
Fitted models: 8r1c
Deposition Authors: Duyvesteyn HME
,
Ren J ,
Stuart DI
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D ,
Supasa P,
Liu C,
Dijokaite-Guraliuc A ,
Duyvesteyn HME ,
Selvaraj M,
Mentzer AJ ,
Das R,
Dejnirattisai W,
Temperton N ,
Klenerman P ,
Dunachie SJ ,
Fry EE ,
Mongkolsapaya J ,
Ren J ,
Stuart DI ,
Screaton GR
(2024) Nat Commun , 15 , 2734 - 2734
,
Supasa P,
Liu C,
Dijokaite-Guraliuc A ,
Duyvesteyn HME ,
Selvaraj M,
Mentzer AJ ,
Das R,
Dejnirattisai W,
Temperton N ,
Klenerman P ,
Dunachie SJ ,
Fry EE ,
Mongkolsapaya J ,
Ren J ,
Stuart DI ,
Screaton GR
(2024) Nat Commun , 15 , 2734 - 2734
Grant Support:
- Wellcome Trust: 203141/A/16/Z (United Kingdom)
- Wellcome Trust: 101122/Z/13/Z (United Kingdom)
- Chinese Academy of Sciences: 2018-I2M-2-002 (China)
- Medical Research Council (MRC, United Kingdom): MR/N00065X/1 (United Kingdom)